Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southern California Research Center
Coronado, California, United States
- Om Research
Lancaster, California, United States
- University of California Davis Health
Sacramento, California, United States
- Peak Gastroenterology Associates
Colorado Springs, Colorado, United States
- Yale School of Medicine
New Haven, Connecticut, United States
- University of Florida - Hepatology Research
Gainesville, Florida, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Florida Research Institute
Lakewood Rch, Florida, United States
- Gi Pros Research
Naples, Florida, United States
- Cleveland Clinic - Florida
Weston, Florida, United States
- Digestive Healthcare of Georgia
Atlanta, Georgia, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Henry Ford Health System
Novi, Michigan, United States
- Washington University School of Medicine in St. Louis
St Louis, Missouri, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Texas Liver Institute
San Antonio, Texas, United States
- University of Virginia
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Jan 2022
- Primary completion
- 30 Jan 2026
- Completion
- 30 Jan 2026
- Last update posted
- 10 Mar 2026
- Registered enrollment
- 42
- Registry id
- NCT05104853
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.